More Business Wire
View Older Stories View Newer Stories-
PVH Corp. to Sell Warners, Olga and True & Co. Businesses to Basic Resources
-
NEUPATH HEALTH ANNOUNCES SUCCESSFUL CLOSING OF UPDATED CREDIT FACILITY
-
Camping World Set to Acquire Youngblood RV in Springfield, MO
-
SolarWinds Showcases Latest Observability Enhancements At AWS re:Invent 2023
-
Bowman Enters into Definitive Purchase Agreement with California Environmental Firm Blankinship & Associates
-
Altus Power Announces New Construction Facility
-
Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023
-
Charge Enterprises Appoints Matthew Chee as Senior Vice President of Growth
-
Advantage Systems Enhances AMB Sierra with Full Branch Impact Capabilities, Gives Executives Deeper View into Individual Branch Performance
-
Empire Petroleum Announces Results for Third Quarter 2023
-
N-able Announces Third Quarter 2023 Results
-
Genius Sports Reports Third Quarter Results Ahead of Expectations and Raises Full-Year Revenue and Group Adj. EBITDA Guidance
-
Altus Power, Inc. Announces Third Quarter 2023 Financial Results
-
Antibe Reports Q2 2024 Interim Financial and Operating Results
-
Modiv Industrial Announces Third Quarter 2023 Results
-
monday.com Announces Third Quarter 2023 Results
-
Blue Yonder Closes Doddle Acquisition, Redefining Profitable and Sustainable Reverse Logistics and Returns Management
-
New Healthcare Professional Component of Let’s Talk About LGSOC to Raise Awareness of Low-Grade Serous Ovarian Cancer as a Distinct and Different Form of Ovarian Cancer Requiring Tailored Resources
-
Abcuro Initiates Part B of Registrational Phase 2/3 MUSCLE Clinical Trial of Ulviprubart (ABC008) for the Treatment of Inclusion Body Myositis
-
Arch MI to Acquire RMIC Companies, Inc.
-
Flow Beverage Corp. Announces Trent MacDonald Appointed Executive Vice-President of Operations
-
Anaergia to Release Third Quarter 2023 Financial Results on November 14, 2023
-
Leading AI-Powered Biopharma BPGbio Appoints Kenin Spivak to Board of Directors
-
Castle Biosciences Ranked Among the Top Workplaces in Houston by the Houston Chronicle for the Third Consecutive Year
-
Network Perception and Claroty Integrate Technology for Continuous OT Cybersecurity Threat Detection
-
Enanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023
-
Incendia Therapeutics Appoints Wendye Robbins, M.D., as Chief Executive Officer and Doses First Patient in Phase 1b Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor
-
Old Dominion Freight Line, Inc. Announces General Rate Increase
-
New Survey Highlights Demand For Corporate Climate Action
-
AECOM announces appointment of Derek Kerr to its Board of Directors
-
Wallbox accelerates Partnership with Sonepar, the World's Largest Electrical Distribution Network
-
Sierra Metals Reports Third Quarter 2023 Operating and Financial Performance
-
J.Jill Appoints Maria Martinez as Chief Human Resources Officer
-
Air Lease Corporation Announces Lease Placement of 18 New Boeing 737-8 Aircraft with EGYPTAIR
-
KalVista Pharmaceuticals Announces Phase 3 KONFIDENT Trial Milestone Achieved
-
Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights
-
UL Solutions Publicly Files Registration Statement for Proposed Initial Public Offering
-
Henry Schein Reports Third-Quarter 2023 Financial Results and Updates Full-Year Guidance
-
Ellington Residential Mortgage REIT Reports Third Quarter 2023 Results
-
Celonis Acquires Symbio, an Innovative Provider of AI-driven Business Process Management Software
-
Board, the leader in Intelligent Planning, appoints data industry veteran Jeff Casale as Chief Executive Officer
-
Sayari Supports Atlantic Council Investigation into Chinese Economic Coercion
-
4M Building Solutions Partners with LCS Facility Group
-
Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan
-
MY DR NOW Expands Presence in Phoenix Metro Area with New Clinics
-
ReNew Announces Date and Conference Call Details for Q2 FY 24 Earnings Report
-
France Télévisions Chooses Eutelsat for UHD Broadcasting Solution to Terrestrial and Satellite Networks Across France
-
FREYR Battery Publishes Shareholder Letter
-
Pantheon launches evergreen private equity fund for global investors on growing private wealth platform
-
Sofinnova Partners Enhances Leadership in Medtech Acceleration with Key Appointments

